Ruslan Horblyuk

966 total citations
41 papers, 712 citations indexed

About

Ruslan Horblyuk is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruslan Horblyuk has authored 41 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 11 papers in Internal Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruslan Horblyuk's work include Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Migraine and Headache Studies (5 papers). Ruslan Horblyuk is often cited by papers focused on Atrial Fibrillation Management and Outcomes (14 papers), Venous Thromboembolism Diagnosis and Management (11 papers) and Migraine and Headache Studies (5 papers). Ruslan Horblyuk collaborates with scholars based in United States, United Kingdom and Spain. Ruslan Horblyuk's co-authors include Jack Mardekian, Allison Keshishian, Xianying Pan, Gregory Y.H. Lip, Shital Kamble, Steve Deitelzweig, Xuemei Luo, Melissa Hamilton, Harold S. Kaplan and Keith Friend and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Ruslan Horblyuk

39 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruslan Horblyuk United States	14	464	271	66	60	58	41	712
C. Suárez Spain	14	370 0.8×	335 1.2×	50 0.8×	84 1.4×	175 3.0×	39	776
Thomas J. Bunz United States	20	740 1.6×	471 1.7×	124 1.9×	182 3.0×	107 1.8×	56	1.0k
Gürbey Ocak Netherlands	18	282 0.6×	221 0.8×	58 0.9×	95 1.6×	162 2.8×	37	863
Luke Bamber United States	14	849 1.8×	655 2.4×	144 2.2×	58 1.0×	187 3.2×	27	1.1k
Kerstin Hogg United Kingdom	13	283 0.6×	382 1.4×	28 0.4×	80 1.3×	166 2.9×	41	588
Henri Boccalon France	13	278 0.6×	212 0.8×	54 0.8×	106 1.8×	191 3.3×	21	638
Janice D. Nunnelee United States	10	272 0.6×	224 0.8×	24 0.4×	57 0.9×	198 3.4×	43	780
Kristine Hommel Denmark	12	864 1.9×	371 1.4×	32 0.5×	236 3.9×	51 0.9×	25	1.2k
Xianying Pan United States	14	922 2.0×	470 1.7×	122 1.8×	146 2.4×	65 1.1×	30	1.1k
Lynn B. Oertel United States	8	980 2.1×	312 1.2×	59 0.9×	95 1.6×	130 2.2×	11	1.1k

Countries citing papers authored by Ruslan Horblyuk

Since Specialization

Citations

This map shows the geographic impact of Ruslan Horblyuk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruslan Horblyuk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruslan Horblyuk more than expected).

Fields of papers citing papers by Ruslan Horblyuk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruslan Horblyuk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruslan Horblyuk. The network helps show where Ruslan Horblyuk may publish in the future.

Co-authorship network of co-authors of Ruslan Horblyuk

This figure shows the co-authorship network connecting the top 25 collaborators of Ruslan Horblyuk. A scholar is included among the top collaborators of Ruslan Horblyuk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruslan Horblyuk. Ruslan Horblyuk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Horblyuk, Ruslan, et al.. (2024). A Systematic Literature Review of Clinical Outcomes in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated in the Third-Line or Later Setting. Blood. 144(Supplement 1). 6443–6443.

Ailani, Jessica, et al.. (2020). PND102 CORRELATION ANALYSIS OF THE CHANGE IN THREE SF-36 DOMAINS WITH CHANGE IN PATIENT-IDENTIFIED MOST BOTHERSOME SYMPTOM AND MONTHLY MIGRAINE DAYS IN PATIENTS WITH CHRONIC MIGRAINE: RESULTS OF THE PROMISE-2 STUDY. Value in Health. 23. S279–S279. 1 indexed citations

Lipton, R.B., et al.. (2019). PND82 IMPACT OF EPTINEZUMAB ON THE HEALTH-RELATED QUALITY OF LIFE (HRQOL) OF PATIENTS WITH EPISODIC OR CHRONIC MIGRAINE: SF-36 ANALYSIS BY MONTHS 1 AND 3 ACROSS THE SPECTRUM OF MIGRAINE. Value in Health. 22. S285–S285. 3 indexed citations

Tepper, Stewart J., et al.. (2019). PND80 RAPID MIGRAINE RESPONSE BY MONTH 1 AND CLINICALLY MEANINGFUL IMPROVEMENTS IN HEALTH RELATED QUALITY OF LIFE (HRQOL) IN PATIENTS WITH MIGRAINE IN PHASE 3 TRIALS OF EPTINEZUMAB. Value in Health. 22. S285–S285. 1 indexed citations

Diamond, Merle L., et al.. (2019). Early Impact of Eptinezumab on the Health-Related Quality of Life (HRQoL) of Patients with Episodic or Chronic Migraine: SF-36 Analysis Across the Spectrum of Migraine (P1.10-025). Neurology. 92(15_supplement). 2 indexed citations

Zanotti, Giovanni, et al.. (2017). Treatment patterns and real world clinical outcomes in ER+/HER2- post-menopausal metastatic breast cancer patients in the United States. BMC Cancer. 17(1). 393–393. 17 indexed citations

Yin, Wesley, et al.. (2017). Association Between Breast Cancer Disease Progression and Workplace Productivity in the United States. Journal of Occupational and Environmental Medicine. 59(2). 198–204. 18 indexed citations

Li, Xiaoyan, Steve Deitelzweig, Allison Keshishian, et al.. (2017). Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice. Thrombosis and Haemostasis. 117(6). 1072–1082. 122 indexed citations

Wang, Feng, et al.. (2017). BLEEDING RISK AMONG JAPANESE NON-VALVULAR ATRIAL FIBRILLATION PATIENTS INITIATED ON APIXABAN, DABIGATRAN, RIVAROXABAN OR WARFARIN IN THE REAL WORLD. Journal of the American College of Cardiology. 69(11). 443–443. 3 indexed citations

10.

Burton, Tanya, Stacey DaCosta Byfield, Gregory L. Smith, et al.. (2016). Clinical and economic outcomes by first-line treatment among women with HR+/HER2– metastatic breast cancer in a large US health plan database. Current Medical Research and Opinion. 32(8). 1417–1423. 12 indexed citations

11.

Horblyuk, Ruslan, Jack Mardekian, Sang Hee Park, et al.. (2016). Abstract 13828: Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin. Circulation. 134(suppl_1). 1 indexed citations

12.

Zanotti, Giovanni, et al.. (2016). Treatment and Patient Burden in ER+ HER2- Metastatic Breast Cancer: Results From a Physician Survey in the United States. Value in Health. 19(3). A171–A171. 1 indexed citations

13.

Keshishian, Allison, Shital Kamble, Xianying Pan, et al.. (2016). Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. Thrombosis and Haemostasis. 116(11). 975–986. 210 indexed citations

14.

Tepper, Ping G., Jack Mardekian, Cristina Masseria, et al.. (2016). REAL-WORLD COMPARISON OF INPATIENT BLEEDING RISK, BLEEDING-RELATED HOSPITALIZATION RATES AND COSTS AMONG NON-VALVULAR ATRIAL FIBRILLATION PATIENTS ON APIXABAN, DABIGATRAN, RIVAROXABAN: COHORTS COMPRISING NEW INITIATORS AND/OR SWITCHERS FROM WARFARIN. Journal of the American College of Cardiology. 67(13). 662–662. 6 indexed citations

15.

Hubbard, Rebecca A., Weiwei Zhu, Ruslan Horblyuk, et al.. (2013). Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammography. Breast Cancer Research and Treatment. 138(3). 879–887. 6 indexed citations

16.

Horblyuk, Ruslan, et al.. (2012). Out of control little-used clinical assets are draining healthcare budgets.. PubMed. 66(7). 64–8. 3 indexed citations

17.

Coon, Cheryl D., et al.. (2012). The Development and Initial Assessment of the Strategy and Leadership Systems Capability Evaluation Survey. The Health Care Manager. 31(4). 332–341. 2 indexed citations

18.

Brown, T. Michelle, Ruslan Horblyuk, Kelly M. Grotzinger, Axel Matzdorff, & Chris L. Pashos. (2012). Patient-reported treatment burden of chronic immune thrombocytopenia therapies. PubMed. 12(1). 2–2. 30 indexed citations

19.

Happe, Laura E., et al.. (2008). Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants. Current Medical Research and Opinion. 25(2). 413–420. 17 indexed citations

20.

Balkrishnan, Rajesh, Bhakti Arondekar, Fabian Camacho, et al.. (2007). Comparisons of Rosiglitazone Versus Pioglitazone Monotherapy Introduction and Associated Health Care Utilization in Medicaid-Enrolled Patients with Type 2 Diabetes Mellitus. Clinical Therapeutics. 29(6). 1306–1315. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact